Limberg-trial

Limberg-flap versus primary closure in the midline after primary excision of a pilonidal sinus

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON27949

Enrollment

Registered

2014-11-04

Start date

2015-01-01

Completion date

Unknown

Last updated

2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sinus pilonidalis

Interventions

Excisie sinus pilonidalis waarna: - primair sluiten midline - Limbergplastiek

Eligibility

Inclusion criteria

Inclusion criteria: - Primary or recurrent pilonidal sinus - Width of fistulacomplex between 1 and 3 centimeter - Signed informed consent - Age: >/= 18 years - Mentally competent

Exclusion criteria

Exclusion criteria: - Patients with an actual abscess - Not able to follow-up - Patients in which woundhealing problems are to be expected (Diabetes type II, immunesupression, chemotherapy, HIV/AIDS) - Not mentally competent - Dementia

Design outcomes

Primary

Measure	Time frame
Tijd, uitgedrukt in weken, tot volledige wondgenezing	—

Secondary

Measure	Time frame
Het aantal wondinfecties, het recidiefpercentage binnen 1 jaar, en een aantal factoren die de morbiditeit na de operatie bepalen zullen worden onderzocht	—

Contacts

Public ContactJ.M. Klaase

Medisch Spectrum Twente Oncology surgeant Postbus 50 000

+31 (0)53 48720 00

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)